Company

"Neuralynx, Inc. is an internationally recognized provider of electrophysiology data recording systems and solutions for neuroscience research, as well as for practical human medical data recording. Neuralynx Inc. specializes in the development of cutting edge electrophysiology data recording systems and experiment accessories while providing quality, long term customer guidance and support."

Company

"Neuroelectrics is a digital brain health company that innovates at the intersection of neuroscience, physics, machine learning, and hardware. We have developed wireless EEG and tDCS/tACS/tRNS stimulation devices with up to 32 channels, amongst other products encompassing software and research services, with the purpose of monitoring and enhancing brain health."

Company

"ANT Neuro is a Dutch corporation specialized in the development, marketing and sales of medical and research applications. ANT Neuro was established in 1997,as a spin-off company of the University of Twente, Enschede. It now has offices located in Hengelo, The Netherlands; Berlin, Germany; London, UK; Philadelphia, USA; and Hong Kong, China.

ANT Neuro specializes in being a single-source provider of high performance products within neuroscience research and neurodiagnostics. Applications include EEG, EMG, MRI, TMS and MEG technology.

Using ANT Neuro products, functional brain information is fused with anatomical scans to gain insight into the working mechanisms of cognition and a variety of brain disorders. Our technology offers a wide range of applications in cognitive neuroscience, neurology and psychiatry."

Company

Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States.

Neuromodulation is the second-oldest and third-largest department of Medtronic. Its products include neurostimulation systems and implantable drug delivery systems for chronic pain, common movement disorders, and urologic and gastrointestinal disorders. The department's revenues in 2014 amounted to $1.9 billion, or 11% of Medtronic's total revenues.

Company

"The RNS System is an award-winning technology developed and manufactured in Silicon Valley that has been recognized for its innovation. Similar to a pacemaker that monitors and responds to heart rhythms, the RNS System is the world's first and only medical device that can monitor and respond to brain activity.



NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders with responsive stimulation. The company's initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide.In addition to treating epilepsy, responsive neurostimulation holds the promise of treating several other disabling medical disorders that impact the quality of life for millions of patients around the world."